Answers are grounded in this paper and cite their sources.
P-glycoprotein (P-gp) functions as a drug efflux pump, mediating multidrug resistance and limiting the efficacy of many drugs. Clearly, identification of potential P-gp substrate liability early in the drug discovery process would be advantageous. We describe a multiple-pharmacophore model that can discriminate between substrates and nonsubstrates of P-gp with an accuracy of 63%. The application of this filter allows large virtual libraries to be screened efficiently for compounds less likely to be transported by P-gp.
No takes yet. Share an insight, caveat, or question.
Penzotti et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: